FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166680147> ?p ?o ?g. }

• W2166680147 abstract "Asymptomatic and symptomatic malaria during pregnancy has consequences for both mother and her offspring. Unfortunately, there is insufficient information on the safety and efficacy of most antimalarials in pregnancy. Indeed, clinical trials assessing antimalarial treatments systematically exclude pregnancy for fear of teratogenicity and embryotoxicity. The little available information originates from South East Asia while in sub-Saharan Africa such information is still limited and needs to be provided. A Phase 3, non-inferiority, multicentre, randomized, open-label clinical trial on safety and efficacy of 4 ACT when administered during pregnancy was carried out in 4 African countries: Burkina Faso, Ghana, Malawi and Zambia. This is a four arm trial using a balanced incomplete block design. Pregnant women diagnosed with malaria are randomised to receive either amodiaquine-artesunate (AQ-AS), dihydroartemisinin-piperaquine (DHA-PQ), artemether-lumefantrine (AL), or mefloquine-artesunate (MQAS). They are actively followed up until day 63 post-treatment and then monthly until 4–6 weeks post-delivery. The offspring is visited at the time of the first birthday. The primary endpoint is treatment failure (PCR adjusted) at day 63 and safety profiles. Secondary endpoints included PCR unadjusted treatment failure up to day 63, gametocyte carriage, Hb changes, placenta malaria, mean birth weight and low birth weight. The primary statistical analysis will use the combined data from all 4 centres, with adjustment for any centre effects, using an additive model for the response rates. This will allow the assessment of all 6 possible pair-wise treatment comparisons using all available data. The strength of this trial is the involvement of several African countries, increasing the generalisability of the results. In addition, it assesses most ACTs currently available, determining their relative ‘-value-’ compared to others. The balanced incomplete block design was chosen because using all 4-arms in each site would have increased complexity in terms of implementation. Excluding HIV-positive pregnant women on antiretroviral drugs may be seen as a limitation because of the possible interactions between antiretroviral and antimalarial treatments. Nevertheless, the results of this trial will provide the evidence base for the formulation of malaria treatment policy for pregnant women in sub-Saharan Africa. NCT00852423" @default.
• W2166680147 created "2016-06-24" @default.
• W2166680147 creator A5002994916 @default.
• W2166680147 creator A5003302916 @default.
• W2166680147 creator A5009095999 @default.
• W2166680147 creator A5021076780 @default.
• W2166680147 creator A5025841934 @default.
• W2166680147 creator A5026367208 @default.
• W2166680147 creator A5026862541 @default.
• W2166680147 creator A5028674277 @default.
• W2166680147 creator A5033754121 @default.
• W2166680147 creator A5037157604 @default.
• W2166680147 creator A5055484845 @default.
• W2166680147 creator A5059059882 @default.
• W2166680147 creator A5060532040 @default.
• W2166680147 creator A5061785276 @default.
• W2166680147 creator A5067418473 @default.
• W2166680147 creator A5068576041 @default.
• W2166680147 creator A5069437397 @default.
• W2166680147 creator A5088258773 @default.
• W2166680147 creator A5091743305 @default.
• W2166680147 date "2015-01-15" @default.
• W2166680147 modified "2023-10-16" @default.
• W2166680147 title "Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria: a multicentre randomized control trial" @default.
• W2166680147 cites W1275343739 @default.
• W2166680147 cites W157218529 @default.
• W2166680147 cites W1829384068 @default.
• W2166680147 cites W1945827446 @default.
• W2166680147 cites W1978712833 @default.
• W2166680147 cites W1987142506 @default.
• W2166680147 cites W2012733980 @default.
• W2166680147 cites W2028628201 @default.
• W2166680147 cites W2037654071 @default.
• W2166680147 cites W2056114294 @default.
• W2166680147 cites W2057464338 @default.
• W2166680147 cites W2085276629 @default.
• W2166680147 cites W2099127084 @default.
• W2166680147 cites W2099534544 @default.
• W2166680147 cites W2102956276 @default.
• W2166680147 cites W2105104428 @default.
• W2166680147 cites W2110377819 @default.
• W2166680147 cites W2111813303 @default.
• W2166680147 cites W2118602162 @default.
• W2166680147 cites W2130249510 @default.
• W2166680147 cites W2134016435 @default.
• W2166680147 cites W2148721643 @default.
• W2166680147 cites W2155629163 @default.
• W2166680147 cites W2185569199 @default.
• W2166680147 doi "https://doi.org/10.1186/1742-4755-12-5" @default.
• W2166680147 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4326323" @default.
• W2166680147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25592254" @default.
• W2166680147 hasPublicationYear "2015" @default.
• W2166680147 type Work @default.
• W2166680147 sameAs 2166680147 @default.
• W2166680147 citedByCount "11" @default.
• W2166680147 countsByYear W21666801472015 @default.
• W2166680147 countsByYear W21666801472016 @default.
• W2166680147 countsByYear W21666801472017 @default.
• W2166680147 countsByYear W21666801472019 @default.
• W2166680147 countsByYear W21666801472020 @default.
• W2166680147 countsByYear W21666801472022 @default.
• W2166680147 countsByYear W21666801472023 @default.
• W2166680147 crossrefType "journal-article" @default.
• W2166680147 hasAuthorship W2166680147A5002994916 @default.
• W2166680147 hasAuthorship W2166680147A5003302916 @default.
• W2166680147 hasAuthorship W2166680147A5009095999 @default.
• W2166680147 hasAuthorship W2166680147A5021076780 @default.
• W2166680147 hasAuthorship W2166680147A5025841934 @default.
• W2166680147 hasAuthorship W2166680147A5026367208 @default.
• W2166680147 hasAuthorship W2166680147A5026862541 @default.
• W2166680147 hasAuthorship W2166680147A5028674277 @default.
• W2166680147 hasAuthorship W2166680147A5033754121 @default.
• W2166680147 hasAuthorship W2166680147A5037157604 @default.
• W2166680147 hasAuthorship W2166680147A5055484845 @default.
• W2166680147 hasAuthorship W2166680147A5059059882 @default.
• W2166680147 hasAuthorship W2166680147A5060532040 @default.
• W2166680147 hasAuthorship W2166680147A5061785276 @default.
• W2166680147 hasAuthorship W2166680147A5067418473 @default.
• W2166680147 hasAuthorship W2166680147A5068576041 @default.
• W2166680147 hasAuthorship W2166680147A5069437397 @default.
• W2166680147 hasAuthorship W2166680147A5088258773 @default.
• W2166680147 hasAuthorship W2166680147A5091743305 @default.
• W2166680147 hasBestOaLocation W21666801471 @default.
• W2166680147 hasConcept C126322002 @default.
• W2166680147 hasConcept C131872663 @default.
• W2166680147 hasConcept C168563851 @default.
• W2166680147 hasConcept C187212893 @default.
• W2166680147 hasConcept C203014093 @default.
• W2166680147 hasConcept C203092338 @default.
• W2166680147 hasConcept C2776120307 @default.
• W2166680147 hasConcept C2778048844 @default.
• W2166680147 hasConcept C2778059366 @default.
• W2166680147 hasConcept C2778371730 @default.
• W2166680147 hasConcept C2778629330 @default.
• W2166680147 hasConcept C2779234561 @default.
• W2166680147 hasConcept C54355233 @default.
• W2166680147 hasConcept C71924100 @default.
• W2166680147 hasConcept C86803240 @default.
• W2166680147 hasConceptScore W2166680147C126322002 @default.
• W2166680147 hasConceptScore W2166680147C131872663 @default.

• next